BridgeMD
New treatment option for Paliative Care
Official title Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)
ClinicalTrials.gov ID: NCT07134881
What this study is testing
- What it's testing
- The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are: Does the website increase ACP engagement of caregivers of patients with serious illness?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- 1\. Patient Participants
- Singapore resident aged 21years and above,
- patient able to identify one main caregiver in the care and medical decision-making for the patient;
- patient able to communicate in either English, Chinese, Malay or Tamil;
- patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain...
You likely can't join if
- Patients unable to identify a caregiver who is a medical decision-maker,
- Patients are currently or was previously healthcare workers; or
- Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test. 3\. Caregiver Participants...
- caregivers are identified as a medical decision-maker for the patient
- Singapore resident aged 21 years and above; and
- able to communicate in English 4\. Caregiver Participants Exclusion Criteria:
See the full eligibility criteria
- 1\. Patient Participants
- Singapore resident aged 21years and above,
- patient able to identify one main caregiver in the care and medical decision-making for the patient;
- patient able to communicate in either English, Chinese, Malay or Tamil;
- patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases. 4b. Patients with spontaneous intracerebral haemorrhage...
- Patients unable to identify a caregiver who is a medical decision-maker,
- Patients are currently or was previously healthcare workers; or
- Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test. 3\. Caregiver Participants Inclusion Criteria:
- caregivers are identified as a medical decision-maker for the patient
- Singapore resident aged 21 years and above; and
- able to communicate in English 4\. Caregiver Participants Exclusion Criteria:
- caregivers are currently or were previously healthcare workers;
- caregivers not involved in primary care of the patient (including providing care to the patient, supervision of care, or involved in making decisions regarding treatment the patient receives); or
- caregivers diagnosed with dementia.
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.